162 related articles for article (PubMed ID: 18398041)
21. MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL.
Dong HJ; Fang C; Fan L; Zhu DX; Wang DM; Zhu HY; Zhuang Y; Miao KR; Liu P; Xu W; Li JY
Int J Cancer; 2012 May; 130(9):2054-61. PubMed ID: 21647873
[TBL] [Abstract][Full Text] [Related]
22. Association of a functional polymorphism in the promoter of the MDM2 gene with risk of nonsmall cell lung cancer.
Lind H; Zienolddiny S; Ekstrøm PO; Skaug V; Haugen A
Int J Cancer; 2006 Aug; 119(3):718-21. PubMed ID: 16496380
[TBL] [Abstract][Full Text] [Related]
23. A cohort study on the association of MDM2 SNP309 with lung cancer risk in Bangladeshi population.
Reza HA; Anamika WJ; Chowdhury MMK; Mostafa MG; Uddin MA
Korean J Intern Med; 2020 May; 35(3):672-681. PubMed ID: 32392664
[TBL] [Abstract][Full Text] [Related]
24. MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism.
Paulin FE; O'Neill M; McGregor G; Cassidy A; Ashfield A; Ali CW; Munro AJ; Baker L; Purdie CA; Lane DP; Thompson AM
BMC Cancer; 2008 Oct; 8():281. PubMed ID: 18828900
[TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk.
Liu G; Wheatley-Price P; Zhou W; Park S; Heist RS; Asomaning K; Wain JC; Lynch TJ; Su L; Christiani DC
Int J Cancer; 2008 Feb; 122(4):915-8. PubMed ID: 17957785
[TBL] [Abstract][Full Text] [Related]
26. MDM2 SNP309 modifies the prognostic significance of the p53 mutational status in patients with ovarian cancer.
Hofstetter G; Berger A; Bauer EM; Schuster E; Wolf A; Chamson M; Müller-Holzner E; Reimer D; Braicu EI; Sehouli J; Ulmer H; Cacsire Castillo-Tong D; Zeillinger R; Concin N
Oncol Rep; 2012 Mar; 27(3):673-7. PubMed ID: 22134502
[TBL] [Abstract][Full Text] [Related]
27. Early onset lung cancer, cigarette smoking and the SNP309 of the murine double minute-2 (MDM2) gene.
Mittelstrass K; Sauter W; Rosenberger A; Illig T; Timofeeva M; Klopp N; Dienemann H; Meese E; Sybrecht G; Woelke G; Cebulla M; Degen M; Morr H; Drings P; Groeschel A; Kreymborg KG; Haeussinger K; Hoeffken G; Schmidt C; Jilge B; Schmidt W; Ko YD; Taeuscher D; Chang-Claude J; Wichmann HE; Bickeboeller H; Risch A
BMC Cancer; 2008 Apr; 8():113. PubMed ID: 18433484
[TBL] [Abstract][Full Text] [Related]
28. MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.
Gryshchenko I; Hofbauer S; Stoecher M; Daniel PT; Steurer M; Gaiger A; Eigenberger K; Greil R; Tinhofer I
J Clin Oncol; 2008 May; 26(14):2252-7. PubMed ID: 18467716
[TBL] [Abstract][Full Text] [Related]
29. Contribution of Murine Double Minute 2 Genotypes to Colorectal Cancer Risk in Taiwan.
Yueh TC; Hung YW; Shih TC; Wu CN; Wang SC; Lai YL; Hsu SW; Wu MH; Fu CK; Wang YC; Ke TW; Chang WS; Tsai CW; Bau DT
Cancer Genomics Proteomics; 2018; 15(5):405-411. PubMed ID: 30194081
[TBL] [Abstract][Full Text] [Related]
30. Role of the MDM2 SNP309 polymorphism in the initiation and early age of onset of nasopharyngeal carcinoma.
Sousa H; Pando M; Breda E; Catarino R; Medeiros R
Mol Carcinog; 2011 Feb; 50(2):73-9. PubMed ID: 21229604
[TBL] [Abstract][Full Text] [Related]
31. The mouse double minute 2 polymorphism is associated with both decreased p53 expression and poor clinicopathological outcomes of gastric cancer.
Bartpho TS; Wattanawongdon W; Tongtawee T
J Cancer Res Ther; 2021; 17(6):1438-1445. PubMed ID: 34916375
[TBL] [Abstract][Full Text] [Related]
32. Association between SNP309 and del1518 Polymorphism in MDM2 Homologue and Esophageal Squamous Cell Carcinoma Risk in Chinese Population of Shandong Province.
Zhang L; Zhu Z; Wu H; Wang K
Ann Clin Lab Sci; 2015; 45(4):433-7. PubMed ID: 26275695
[TBL] [Abstract][Full Text] [Related]
33. Lack of association between the MDM2-SNP309 polymorphism and breast cancer risk.
Petenkaya A; Bozkurt B; Akilli-Ozturk O; Kaya HS; Gur-Dedeoglu B; Yulug IG
Anticancer Res; 2006; 26(6C):4975-7. PubMed ID: 17214373
[TBL] [Abstract][Full Text] [Related]
34. Effect of MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in Singapore.
Chua HW; Ng D; Choo S; Lum SS; Li H; Soh LY; Sabapathy K; Seow A
BMC Cancer; 2010 Mar; 10():88. PubMed ID: 20219101
[TBL] [Abstract][Full Text] [Related]
35. MDM2 gene SNP309 T/G and p53 gene SNP72 G/C do not influence diffuse large B-cell non-Hodgkin lymphoma onset or survival in central European Caucasians.
Bittenbring J; Parisot F; Wabo A; Mueller M; Kerschenmeyer L; Kreuz M; Truemper L; Landt O; Menzel A; Pfreundschuh M; Roemer K
BMC Cancer; 2008 Apr; 8():116. PubMed ID: 18433491
[TBL] [Abstract][Full Text] [Related]
36. Murine double-minute 2 homolog single nucleotide polymorphism 309 and the risk of gynecologic cancer.
Ueda M; Yamamoto M; Nunobiki O; Toji E; Sato N; Izuma S; Okamoto Y; Torii K; Noda S
Hum Cell; 2009 May; 22(2):49-54. PubMed ID: 19379464
[TBL] [Abstract][Full Text] [Related]
37. MDM2 SNP309 does not confer an increased risk to oral squamous cell carcinoma but may modulate the age of disease onset.
Hamid S; Yang YH; Peng KN; Ismail SM; Zain RB; Lim KP; Wan Mustafa WM; Abraham MT; Teo SH; Cheong SC
Oral Oncol; 2009 Jun; 45(6):496-500. PubMed ID: 18804411
[TBL] [Abstract][Full Text] [Related]
38. An updated meta-analysis on the association of MDM2 SNP309 polymorphism with colorectal cancer risk.
Qin X; Peng Q; Tang W; Lao X; Chen Z; Lai H; Deng Y; Mo C; Sui J; Wu J; Zhai L; Yang S; Li S; Zhao J
PLoS One; 2013; 8(9):e76031. PubMed ID: 24098760
[TBL] [Abstract][Full Text] [Related]
39. MDM2 SNP309 and p53 Arg72Pro in cutaneous melanoma: association between SNP309 GG genotype and tumor Breslow thickness.
Capasso M; Ayala F; Avvisati RA; Russo R; Gambale A; Mozzillo N; Ascierto PA; Iolascon A
J Hum Genet; 2010 Aug; 55(8):518-24. PubMed ID: 20535124
[TBL] [Abstract][Full Text] [Related]
40. TP53 and MDM2 polymorphisms and the risk of endometrial cancer in postmenopausal women.
Zając A; Smolarz B; Stachowiak G; Wilczyński JR
Med Oncol; 2014 Nov; 31(11):286. PubMed ID: 25316267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]